Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies.
J. Pathol.; 226: 132–142. 2012 Jan; doi: 10.1002/path.2984.
Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease.
The Journal of Biological Chemistry; 2012 Feb 3; The Journal of Biological Chemistry, 287, 3842-3849. doi: 10.1074/jbc.M111.277061.
Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease.
Cell; Volume 149, Issue 1, 232-244, 2012 March 30 DOI: 10.1016/j.cell.2012.02.016.
Nanopore Analysis: An emerging technique for studying the folding and misfolding of proteins.
Prion; 2012 Apr 1;6(2):116-23. Epub 2012 Apr 1.pp 116-123 DOI /10.4161/pri.18665.
. United States Patent Application 20120087861;; 2012 Apr 12; DOI: y2012/0087861.html.
Human Anti-Tau Antibodies.
Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models.
Neurobiology of Aging; Volume 33, Issue 8, Pages 1493-1856 (August 2012) DOI 10.1016/j.neurobiolaging.2012.05.010.
Constitutive secretion of tau protein by an unconventional mechanism.
Neurobiology of Disease; Available online 2 June 2012 DOI 10.1016/j.nbd.2012.05.021.
Development and assessment of sensitive immuno‐PCR assays for the quantification of cerebrospinal fluid three‐ and four‐repeat tau isoforms in tauopathies.
Journal of Neurochemistry; https://doi.org/10.1111/j.1471-4159.2012.07911.x.
Methods for Measuring Tau Pathology in Transgenic Mouse Models.
IOS Press; DOI 10.3233/JAD-2012-121354, PMID: 22976073 (Pay to View).
A Selected Reaction Monitoring (SRM)-Based Method for Absolute Quantification of A 38, A 40, and A 42 in Cerebrospinal Fluid of Alzheimer’s Disease Patients and Healthy Controls.
IOS Press; DOI: 10.3233/JAD-2012-121471.